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Summary
QUESTIONS UNDER STUDY: Suicidal behaviour is a
major source of burden of disease. While most studies fo-
cus on cost associated with completed suicides, data on
costs of, non-lethal, suicide attempts are lacking. The aim
of this study was to assess direct annual cost of suicide at-
tempts in Basel in 2003 from a health services perspective.
METHODS: Retrospective cost-of-illness-study of the
Basel cohort of the 2003 WHO/EURO-Multicentre Study
on Parasuicide. We extracted cost information from the two
major hospitals involved in treatment of these patients. We
determined overall cost, compared cost medians and iden-
tified variables associated with higher cost by means of lo-
gistic regression.
RESULTS: For 2003, treatment of suicide attempters in
Basel’s main hospitals amounted to 3,373,025 Swiss
Francs (CHF), mainly attributable to psychiatric care.
Mean and median cost per case were 19,165 CHF and
6,108 CHF, respectively. Based on these findings, the ex-
trapolated direct medical costs for medical treatment of sui-
cide attempts in Switzerland per year amount to 191 mil-
lion CHF. Parameters associated with high costs were age
above 65 (p<0.01), using a hard method (p<0.05), receiv-
ing intensive care (p<.05), and lethal intention (p<0.05).
The ICD-10 diagnostic category F3 was associated with
significantly higher costs than F1 (p<0.05) and F4
(p<0.05).
CONCLUSIONS: Attempted suicide produces substantial
direct medical costs, which are only a part of the financial
burden. Prevention targeting mood disorders, the elderly
and the use of hard methods may be most cost-effective.
Further research should aim at identifying additional indir-
ect costs and the cost-effectiveness of prevention measures.
Key words: attempted suicide; parasuicide; self-harm;
cost; economic burden
Introduction
Every year, nearly one million people commit suicide
worldwide, and suicide is among the 20 leading causes
of death [1]. International health programmes such as the
WHO programme “SUPRE” [2] have set mental health and
suicide prevention as their priority. Data on completed sui-
cides are widely available and indicate a substantial loss of
potential years of life [3, 4]. However, data on attempted
suicide are scarce, although medically, socially, ethically
and economically significant. Suicide attempts are estim-
ated to outnumber suicides by 10 to 20 times [5]. Interna-
tional prevalence rates for suicide attempts vary between
0.4% and 4.2% [6], suggesting that suicide attempts might
incur considerable costs [7, 8].
Compared to other European countries, Switzerland has an
above-average suicide rate. The lifetime prevalence of sui-
cide attempts in Zurich, Switzerland’s most populous can-
ton/city, was found to be 3.8% in 20–30 year olds (5.4%
women, 2.1% men; [9]), while surveys among Swiss ad-
olescents found a lifetime prevalence rate of 3.0% [10].
Based on records of registered suicide attempts in Bern,
Switzerland’s capital, the total number of suicide attempts
per year was estimated to be at least 10 000 for Switzerland
as a whole [11]. The actual number of suicide attempts in-
cluding non-registered cases is around 15 000 to 25 000
according to conservative estimates [12], suggesting a life-
time prevalence of about 10%. Suicide attempts are more
common in women [13]. Prevalence rates for Bern between
1989 and 1995 were 160/100 000 in women and 100/100
000 in men [12].
Few data are available regarding the associated cost struc-
ture. Published studies focus on the costs of completed sui-
cides [14, 15], which create indirect rather than direct costs
resulting mainly from lost production. Direct costs, e.g. at-
tributable to medical care, transportation, autopsy or funer-
al services, are of minor significance. Data available on
suicide attempts show a reverse pattern [16, 17]. A study
commissioned by the government of New Zealand [18] as-
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sessed both the financial and social costs of completed and
attempted suicides. Regarding completed suicides, costs
were dominated by lost productivity with 153.8 million
Swiss francs (CHF) spent, and only a small fraction was at-
tributable to direct costs (~CHF 3.6 million). For attempted
suicides, the costs of medical care were approximately 1.5
times higher (~CHF 14.6 million) than those accrued due to
lost production (~CHF 10 million). This shows that in the
case of suicide attempts the main cost driver is direct med-
ical cost. These findings are supported by a study conduc-
ted in Ireland [17], which comes to the conclusion that dir-
ect medical cost due to suicide attempts were around CHF
24.3 million in 2002, whereas the indirect cost summed
up to only CHF 10.9 million. This research underlines the
principal role of direct costs in the economic impact of sui-
cide attempts. Therefore an assessment of the direct medic-
al costs is a first step toward gaining a comprehensive un-
derstanding of the cost structure of attempted suicides. The
identification of patient characteristics associated with high
costs could provide starting-points for cost-effective pre-
vention measures. Aim of this retrospective cost-of-illness
study was to identify from a health services perspective the
annual cost of attempted suicide of the Basel cohort of the
WHO/EURO Multicentre Study on Suicidal Behaviour for
the year 2003.
Methods
Study design
We conducted a cost-of-illness-study with retrospective
analysis of direct medical costs for those suicide attempters
registered in the WHO/EURO Multicentre Study on
Suicidal Behaviour in Basel in 2003. Information on costs
and patient characteristics were linked to identify factors
influencing the cost structure of attempted suicide.
Setting
The canton Basel-City comprises Switzerland's third most
populous city and two surrounding municipalities. The age
distribution of the population in Basel and Switzerland, re-
spectively, was 17.2% and 22.9% of citizens up to 19 years
of age, and 21.0% and 15.4% of citizens aged 64 years and
more. In Basel-City the proportion of individuals with a
history of migration was higher than in the general Swiss
population with 30.3% vs. 21.1%. The gender ratio, edu-
cational background, the labor force participation rate and
the unemployment rate of Basel were approximately simil-
ar [19].
The University Hospital (UH), including a psychiatric
crisis intervention ward, and the University Psychiatric
Hospital (UPH) are the major medical service providers of
the region with a mainly urban population and a catchment
area of approximately 187 000 people in 2003 [19]. Ap-
proximately 50% of suicide attempters are treated in outpa-
tient care mandated by the participating clinics, while those
patients suffering from ongoing severe suicidal ideation
following attempted suicide are typically treated in inpa-
tient care.
Dataset of the WHO/EURO multicentre study on
suicidal behaviour
The WHO/EURO Multicentre Study on Suicidal Beha-
viour collected data on individuals who attempted suicide
in Basel in 2003. Inclusion criteria were attempted suicide
as defined by the WHO/EURO Study (for details see [20])
and age 18 years and above. Parasuicide was defined as “an
act with nonfatal outcome, in which an individual deliber-
ately initiates a non-habitual behaviour that, without inter-
vention from others, will cause self-harm, or deliberately
ingests a substance in excess of the prescribed or generally
recognised therapeutic dosage, and which is aimed at real-
ising changes which the subject desired via the actual or
expected physical consequences” [1, 8]. The definition in-
cludes acts that are interrupted before actual self-harm oc-
curs, such as the behaviour of a person who lies across rail-
way tracks with the intention of being run over by a train,
but is rescued before the train arrives. Self-harmful acts
by people who do not understand the meaning or conse-
quences of their own actions were excluded. Repeated de-
liberate self-harm with the intention to reduce stress such
as for instance habitual cutting, e.g., by patients suffering
from Borderline personality disorder, were excluded as
well. The terms “parasuicide” and “suicide attempt” are
used interchangeably in this paper. In addition to socio-
demographic variables, details on suicide attempts, meth-
ods according to ICD-10 X-Code [21], treatment and clin-
ical psychiatric diagnoses were recorded.
For statistical analysis, we classified the variables of the
WHO/EURO Study as follows: Age was categorised into
three groups (18–24 years, 25–64, 65 and above), chosen
to reflect the different stages in the social and working life
of patients. Categories of suicide attempt methods ICD-10
X60–X69, including self-poisoning, were subsumed in the
category “soft method”; X70-X84, including acts such as
hanging, cutting, running into traffic, jumping, burning or
drowning, were labeled “hard methods” [22]. Attempted
suicides were also classified according to underlying inten-
tions. Patients expressing a profound death wish were sub-
sumed under the variable “lethal intention”. Parasuicidal
gestures and pauses, deliberate self-harm or overdoses due
to dependency were classified as “non-lethal intention”.
ICD-10 diagnostic categories F5 and F6 were merged due
to the low case numbers.
The local ethics committee approved both the WHO/
EURO Multicentre Study on Suicidal Behaviour as well as
our study and declined the necessity of obtaining informed
consent.
We identified 195 participants fulfilling the inclusion cri-
teria. Of these, 15 were dropped due to missing data re-
garding costs and 4 were dropped due to supplementary
insurance (which could otherwise distort results due to dif-
ferences in accounting methods). Table 1 shows the charac-
teristics of the remaining 176 participants, which also rep-
resent the basis for the calculation of total cost. For the
logistic regression, only 161 participants were included,
while 15 were excluded due to missing data. The charac-
teristics of the excluded participants did not differ signific-
antly from those included in the logistic regression.
There is a lack of official statistics on suicide attempts in
Switzerland. Therefore, to assess representativeness of our
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sample, we used data published on monitoring of suicid-
al behaviour in the catchment area of Bern covering the
years 2004 until 2010 [23], permitting comparison of sev-
eral sample characteristics, although we did not conduct
any statistical tests. Mean age was similar with 38.9 in
Basel vs. 37.4 in Bern. There was a slightly higher pro-
portion of women in Basel with 68% compared to Bern
with 56.6%. In Bern, 56.7% had a partner vs 58% in Basel.
Of the Basel group, 44% had a history of migration vs.
24% of the Bern group. This difference may be partly ex-
plained with the overall higher percentage of individuals
with a history of migration in Basel with roughly 10%.
Bern had 44% of repeaters vs 50% in Basel and soft meth-
ods were slightly higher in Basel with 73% vs Bern with
64.2%. Further comparisons cannot be made due to lack of
data but we believe that the underlying dataset can be con-
sidered fairly representative for Switzerland regarding the
main variables.
Assessment of costs
We assessed all direct medical costs for psychiatric and
somatic care on inpatient or outpatient level by the parti-
cipating hospitals following each suicide attempt occurring
between 1 January and 31 December 2003, for a period
of 12 months. Costs of inpatient and outpatient care were
identified separately for each case by the hospitals’ finan-
cing and controlling departments. Cost items included em-
ployee time and the cost of medication and diagnostics.
Treatments delivered in the UH are given a specific case
number that we used to identify associated costs. For the
UPH, all hospitalisations initiated within one week of a sui-
cide attempt were included. We checked rehospitalisations
initiated within four weeks of discharge from a hospitalisa-
tion due to suicide attempt by studying patient records and
included costs in the data set in case of an ongoing suicidal
crisis. We applied the same inclusion procedure to all fol-
lowing hospitalisations. In a second step, costs of each hos-
pitalisation were calculated using the hospital’s accounting
Table 1: Sample characteristicsa of the WHO/EURO-study (n = 176).
Characteristic n %
Age in years (mean, SD) 38.9 ± 17.6
Gender
Female 119 68
Male 57 32
Occupation
In education 17 10
Full occupation 45 26
At home 29 16
Retirement 17 10
Invalidity pension 57 32
Partner
Yes 70 40
No 102 58
History of migration
Yes 70 40
No 99 56
Education
More than 9 years 76 43
Up to 9 years 78 44
Diagnostic group (ICD-10)
F1 18 10
F2 17 10
F3 68 39
F4 49 28
F5/6 18 10
Repeater
Yes 88 50
No 81 46
Method of suicidal actionb
Hard 47 27
Soft 128 73
Intentionc
Lethal 89 51
Non-lethal 86 49
Treatment on ICU (intensive care unit)
Yes 27 15
No 149 85
a Percentages not adding up to 100 are due to missing information.
b Soft methods according to ICD-10 X60-X69, including self-poisoning; hard methods ICD-10 X70-X84, including hanging, cutting, running into traffic, jumping, burning or
drowning.
c Intention of dying as opposed to parasuicidal gestures and pauses, deliberate self-harm or overdoses due to dependency.
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system. If patients made repeated suicide attempts, during
or after a hospitalisation, we allocated costs by separating
the treatment costs according to the date of suicide attempt
and therefore treated each suicide attempt as a different
case.
Outpatient care was only included for subjects not already
in treatment at the time of the attempt and when it was per-
formed in the UH or UPH. We assumed that the outpatient
treatment was initiated as a consequence of the suicide at-
tempt, and that costs were directly attributable. The first
outpatient appointment had to take place within two weeks
of the suicide attempt in order to be included in the costs.
The clinics used for this study collaborate closely in the
care of suicide attempters, and referrals between both clin-
ics were common. Of the sample, 17 were treated exclus-
ively in the UH; 80 only in the UPH; and 79 in both hos-
pitals. Thirty-five patients were treated on the psychiatric
crisis intervention ward of the UH.
The close cooperation of the two clinics might have pro-
duced the problem of double accounting. The respective
items were identified on the basis of billing dates and in-
cluded only once in the overall cost.
Statistical methods
Statistical analysis was conducted using the “R” environ-
ment (version 2.9.0). To identify factors influencing the
cost of suicide attempts, we initially compared the median
cost per case across categories within potentially relevant
variables. We used the Mann–Whitney U-Test or the
Kruskal-Wallis-Test at the significance level of 5% to es-
tablish whether statistically significant differences exist.
The exclusion of outliers had no influence on the results.
In health economics analysis, a highly skewed distribution
of treatment costs is a common phenomenon. To analyse
the concentration of the total costs in our sample, we cal-
culated the Gini-coefficient [24]. This measure represents
the dispersion of costs across patients. A coefficient of zero
would imply that treatment costs are the same for all pa-
tients. A value of one on the other hand would indicate
that one single person incurs all costs. We then calculated
a cost-concentration curve, which in turn informed the lo-
gistic regression analysis of the probability of being a high-
cost case.
Results
Overall cost and extrapolated cost for Switzerland
Treatment of suicide attempters in the two main Basel-City
hospitals in 2003 cost approximately CHF 3,373,025 (the
exchange of US dollars to Swiss francs was 1.24 on 31
December 2003). The largest part (CHF 2,730,757; ~81%)
was attributable to treatments in the UPH. Only approx-
imately one fifth of the costs (CHF 642,268; ~19%) was
caused by treatment in the UH. Table 2 shows the costs per
day and the departments involved. Mean and median cost
per case was 19,165 CHF (SD = 38,052) and 6,108 CHF
(interquartile range [3,011; 17,311]), respectively. Table 3
shows indicators of cost per case.
A report by the Swiss Federal Office of Public Health [12]
estimated that about 10 000 of a total of 15 000–25 000
suicide attempts in Switzerland entail medical treatment.
Based on this estimate and the mean cost per case, the ex-
trapolated direct medical costs for the treatment of suicide
attempts in Switzerland amounted to 191 million CHF in
2003.
Comparison of medians
The comparison of cost medians yielded significant differ-
ences for the following variables: gender, age, method of
suicide, diagnosis, suicide intention, history of migration
and treatment in the intensive care unit. The comparison of
cost medians is shown in Table 3.
Cost for suicide methods by ICD-10 X groups
Table 4 displays direct psychiatric and somatic cost by
method of suicide attempt. Because of low case numbers,
we abstained from calculation of statistical tests, with the
exception of category X61, where somatic costs where sig-
nificantly higher than psychiatric costs (p = 0.012 from
Mann-Whitney U-Test).
Gini-coefficient, cost-concentration and logistic
regression
In our sample, the value of the Gini-coefficient is 0.69. This
suggests that the majority of patients incurred low or mod-
erate treatment costs, whereas only a relatively small pro-
portion of patients incurred a large proportion of total costs.
Table 2: Treatment frequencies and costs in Swiss francs (CHF) by inpatient and outpatient status.
Hospital Number of days Cost/day (CHF) Total cost (CHF) % of Total inpatient cost
University hospital (UH) inpatient
Surgical 34 1,663 56,538 2
Internal medicine 89 1,239 110,253 3
Intensive care unit 78 2,055 150,048 5
Psychiatric 227 1,079 239,608 7
University Psychiatric Hospital (UPH) Inpatient 5,098 536 2,730,757 83
Inpatient total 5,526 595 3,287,203 97a
Number of cases Cost/case (CHF) Total cost (CHF) % of total outpatient cost
UH Outpatient
Surgical 21 900 18,907 22
Internal nedicine 78 562 43,850 51
Other 17 584 9,928 12
Psychiatric 27 487 13,137 15
Outpatient Total 143 600 85,822 3a
a Percentage of total costs (inpatient plus outpatient).
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Figure 1 shows the cost concentration curve. The slope of
the curve increases steeply after the third quartile. About
80% of costs are caused by only 20% of the study popu-
lation. This strong concentration implies that the preven-
tion of relatively few suicide attempts could reduce the ma-
jority of costs. We were therefore interested in identifying
Table 3: Indicators of per person cost.
Variable Mean SD Median 1st quartile 3rd Quartile pa
Age 0.000
18–24 10,892 21,703 4,076 842 8,266
25–64 19,818 44,737 6,362 3,203 15,013
64 and above 32,591 26,282 28,122 13,469 41,536
Methodb 0.015
Hard 28,907 59,197 9,141 3,805 36,363
Soft 14,963 25,945 5,112 2,141 11,612
Method by ICD-10 X-code 0.006
X60 intentional self-poisoning by and exposure to nonopioid
analgesics, antipyretics and antirheumatics
5,134 7,654 3,519 1,624 4,450
X61 intentional self-poisoning by and exposure to antiepileptic,
sedative-hypnotic, antiparkinsonism and psychotropic drugs, not
elsewhere classified
17,399 27,293 6,127 3,175 20,079
X62 intentional self-poisoning by and exposure to narcotics and
psychodysleptics [hallucinogens], not elsewhere classified
17,849 24,587 8,334 5,634 20,550
X63 intentional self-poisoning by and exposure to other drugs
acting on the autonomic nervous system
19,482 42,777 5,444 3,800 6,942
X64 intentional self-poisoning by and exposure to other and
unspecified drugs, medicaments and biological substances
6,528 NAc 6,528 NA NA
X65 intentional self-poisoning by and exposure to alcohol 8,476 NA 8,476 NA NA
X66 intentional self-poisoning by and exposure to organic solvents
and halogenated hydrocarbons and their vapours
2,370 NA 2,370 NA NA
X70 intentional self-harm by hanging, strangulation and suffocation 84,068 118,840 35,414 23,153 50,037
X71 intentional self-harm by drowning and submersion 412 99 412 377 447
X76 intentional self-harm by smoke, fire and flames 4,540 4,098 3,198 2,240 6,170
X78 intentional self-harm by sharp object 16,095 22,110 7,955 3,580 16,327
X79 intentional self-harm by jumping or lying before moving object 15,749 19,820 7,844 5,055 18,538
X80 intentional self-harm by jumping from a high place 21,850 19,413 16,012 6,595 37,396
X83 intentional self-harm by other specified means 19,365 25,583 19,365 10,320 28,410
Not specified 15,102 NA 15,102 NA NA
Diagnostic group (ICD 10) 0.000
F1 11,908 14,310 6,370 4,882 11,996
F2 58,800 95,536 11,402 7,231 55,289
F3 21,615 29,237 8,451 3,189 32,568
F4 6,320 9,105 4,098 751 6,353
F6 13,531 15,976 7,104 4,222 9,281
Intentiond 0.000
Lethal 28,046 49,047 9,677 48,767 37,099
Non-lethal 9,200 17,518 4,076 763 8,266
Gender 0.003
Male 27,106 55,559 9,128 4,877 27,596
Female 14,723 25,147 4,870 1,735 12,430
History of migration 0.000
Yes 13,772 44,015 4,114. 1,276 91,334
No 23,054 34,244 8,476 4,096 35,762
Intensive care 0.007
Yes 27,432 34,424 9,878 6,132 40,348
No 17,157 38,570 5,140 2,370 12,818
a P-value of Mann-Whitney U-Test (for 2 groups) or of Kruskal-Wallis-Test (for 3 or more groups).
b Soft methods according to ICD-10 X60-X69, including self-poisoning; hard methods ICD-10 X70-X84.
c Only one case, standard deviation cannot be calculated.
d Intention of dying as opposed to parasuicidal gestures and pauses, deliberate self-harm or overdoses due to dependency.
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what variables influence the probability of making a pa-
tient become one of the few high-cost cases rather than as-
sessing the average effect of certain patient characteristics.
Consequently we conducted a logistic regression analys-
is to identify the variables influencing the likelihood of a
suicide attempt falling in the high-cost category. The cut-
off point between “low-cost cases” and “high-cost cases”
was set at the third quartile. This point was chosen because
the increase in the slope seems to be highest around this
quartile. We did not try to calculate an optimal cut-off value
because using such a method could seriously bias the res-
Figure 1
Concentration curve of direct medical costs of suicide attempts (n =
176).
ulting estimates [25]. However, we did check whether our
results are robust to the alteration of the cut-off value. For
cut-off values between the 7th and 8th decile, the results
are qualitatively very similar.
The final regression model was based on 161 observations
and included the following variables: age, method, dia-
gnostic group, suicide intention, sex, history of migration
and intensive care. Fifteen patients were excluded because
not all the characteristics used in the logistic regression
were recorded. There was no indication of multicollinearity
of independent variables, which was tested for by calcula-
tion of a correlation matrix and variance inflation factors.
Detailed results are shown in Table 5.
Individuals older than 64 were significantly more likely to
be in the high-cost group with an odds ratio (OR) of 6.48
(p <0.01) compared to the group of 25–64 year olds. There
was no statistically significant difference between patients
aged 18–25 years and those aged 25–64 years. Patients who
had attempted suicide using “hard methods” had a high-
er likelihood of being in the high-cost group (OR 3.38,
p <0.05) although the somatic treatment was not signific-
antly more expensive than for those using soft methods.
Compared to the reference category ICD-10 F3, diagnost-
ic categories F1 (OR 0.18, p <0.05) and F4 (OR 0.16, p
<0.05) had significantly lower odds of being in the high-
cost group. F2 and F5/6 showed no statistically significant
difference with respect to F3. The likelihood of falling into
the high-cost category was three times higher for subjects
with severe suicidal ideation compared to those without
lethal intention (OR 3.02, p <0.05). Intensive care treat-
ment led to a higher likelihood (OR 3.59, p <.05) of be-
ing in the high-cost group compared to the subjects with no
Table 4: Direct psychiatric and somatic cost by method (ICD-10 X code) of suicide attempt.
Method Psychiatric, n = 176 (p = 0.035a) Somatic, n = 156 (p = 0.17a)
Mean SDb Median IQRc n Mean SDb Median IQRc n
X60 intentional self-poisoning by and exposure to nonopioid
analgesics, antipyretics and antirheumatics
2,643 7,864 0 0–1,025 23 2,491 2,277 1,537 696–4,115 23
X61 intentional self-poisoning by and exposure to antiepileptic,
sedative-hypnotic, antiparkinsonism and psychotropic drugs, not
elsewhere classified
13,513 26,905 254 0–16,111 90 4,115 4,142 3,505 730–5,322 85
X62 intentional self-poisoning by and exposure to narcotics and
psychodysleptics [hallucinogens], not elsewhere classified
8,294 11,797 3,714 2,013–9,995 4 9,555 12,807 4,620 3,531–10,645 4
X63 intentional self-poisoning by and exposure to other drugs
acting on the autonomic nervous system
17,463 43,363 1,753 0–5,353 8 2,308 2,409 569 472–4,132 7
X64 intentional self-poisoning by and exposure to other and
unspecified drugs, medicaments and biological substances
3,432 NAd 3,432 NA 1 3,096 NA 3,096 NA 1
X65 intentional self-poisoning by and exposure to alcohol 0e NA 0 NA 1 8,476 NA 8,476 NA 1
X66 intentional self-poisoning by and exposure to organic solvents
and halogenated hydrocarbons and their vapours
1,785 NA 1,785 NA 1 585 NA 585 NA 1
X70 intentional self-harm by hanging, strangulation and suffocation 81,036 120,736 35,414 11,856–49,565 9 6,822 12,047 1,169 377–7,613 4
X71 intentional self-harm by drowning and submersion 0 NA 0 NA 2 412 99 412 377–447 2
X76 intentional self-harm by smoke, fire and flames 1,184 1,292 991 496–1,777 3 3,356 5,013 636 463–4,889 3
X78 intentional self-harm by sharp object 13,651 22,358 1,849 0–14,718 19 2,902 2,469 2,335 1,158–3,619 16
X79 intentional self-harm by jumping or lying before moving object 15,112 20,375 7,664 4,508–18,269 4 1,273 1,290 1,273 817–1,729 2
X80 intentional self-harm by jumping from a high place 12,749 15,192 8,101 450–19,563 8 10,401 19,898 2,375 2,035–5,107 7
X83 intentional self-harm by other specified means 17,953 23,586 17,953 9,614–26,292 2 1,412 1,997 1,412 706–2,118 2
Not specified 1,360 NA 1,360 NA 1 13,742 NA 13,742 NA 1
a P-value of Kruskal-Wallis-test.
b Standard deviation.
c Interquartile range.
d Only one case, standard deviation cannot be calculated.
e A value of 0 can occur, when a patient is referred from one clinic to another but is discharged on the same day. In this case, costs are only allocated to the primary
treatment to avoid double billing.
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such treatment. Gender showed no statistically significant
difference with an OR of 1.88 (p = 0.23) for females. While
in univariate analysis, patients who were born in Switzer-
land created significantly higher costs than individuals with
a history of migration, this finding was no longer signific-
ant in the regression analysis (OR for being an individual
with a history of migration 0.51, p = 0.20).
Discussion
In Switzerland, official statistics on suicide attempts and
thus detailed numbers regarding their costs are lacking. An
official Swiss government report [12] estimated that, in
Switzerland, only 10,000 of overall 15,000–25,000 suicide
attempts are treated medically, with an extrapolated cost of
approximately CHF 78.6 million. Little is known about the
treatment of the remaining 5000 to 15 000 cases, which
may largely consist of informal care. The present analys-
is based on the dataset of the WHO/EURO Multicentre
Study on Suicidal Behaviour estimated total direct med-
ical annual costs of CHF 3,373,025 in 2003 with a mean
cost per case of 19,165 CHF in the canton of Basel-City.
Based on our study, the extrapolated direct medical costs
for the estimated 10,000 medically treated suicide attempts
in Switzerland amount to 191 million CHF annually. As-
suming the total number of suicide attempts in Switzerland
to be about twice that number, the costs could be consid-
erably higher. A rough comparison with the direct costs of
treating common diseases can be made on the grounds of
estimates for pharmaceutical cost groups provided by Beck
et al. [26]. For example, the cost of treating kidney dis-
eases was estimated to amount to 41,800 CHF per person
per year. The treatment of individuals with the HI-Virus or
AIDS cost 18,348 CHF per person per year.
To our knowledge, this is the first study investigating the
influence of demographic and psychosocial variables on
the cost structure of suicide attempts. The present analysis
showed that 88% of the estimated total direct medical an-
nual costs of CHF 3,373,025 in 2003 were spent on psy-
chiatric treatment. These costs correlate strongly with the
duration of hospitalisation due to the day-rate remuneration
scheme in the UHP. These findings are in line with a recent
UK-study on the cost of self-harm, which showed that 66%
of overall costs were accrued in inpatient psychiatric care
[27]. Complex cases, often entailing long-term physical
and mental rehabilitation, are referred to the UPH as soon
as stabilisation has been achieved. Physical treatment is
then performed on an outpatient basis in the UH and is al-
located to psychiatric costs for duration of the psychiatric
hospitalisation although accrued due to somatic treatment.
Additionally, suicide attempters using "hard methods" may
be considered more seriously ill and consequently assigned
to inpatient psychiatric care, possibly extending over a pro-
longed period, as use of “hard methods” and treatment in
the ICU were significantly associated with higher costs
both in univariate and multivariate analysis.
Patients aged older than 64 had significantly higher odds
(6.48) of accruing high costs after a suicide attempt com-
pared to the largest age-group (25–64 years). Suicidal be-
haviour in elderly people, therefore, seems to be not only
a neglected, but also an expensive, problem. This finding
becomes even more relevant in light of other research res-
ults regarding suicidal behaviour in this age group: About
71–95% of suicide victims aged 65 years or more suffered
from a major mental disorder [28]. Other associated risk
factors are physical illness, poverty or social isolation [29].
However, few elderly people with suicidal ideation seek
out mental health services; most look for help in primary
care [30–32]. Thus, prevention strategies are more likely to
reach the elderly there [33, 34], and may be highly cost-ef-
fective.
Mental health problems like depression and other mood
disorders, impulse-control disorders, anxiety disorders,
psychosis and substance misuse have been demonstrated to
have an important impact on suicidal behaviour [8, 35–39].
This is compatible with our finding of the largest subgroup
of our dataset suffering from affective disorders (ICD-10
F3). Compared to the other diagnostic categories (ICD–10
F1, F2, F4 and F5/6) this group was more likely to occur in
the high-cost group. This finding suggests that prevention
measures improving recognition and treatment quality of
mood disorders may be cost-effective strategies, and sup-
ports activities like those of the European Alliance against
Depression [34, 40].
Surprisingly, gender was not significantly associated with
high costs in the regression analysis. Men have a higher
risk of completing suicide, since they tend to use more vi-
olent methods [41]. We therefore also expected them to in-
cur higher costs with attempted suicides. Indeed, univariate
analysis showed significantly higher costs for male sub-
jects, but when checking for other variables in the regres-
sion analysis, males did not have significantly higher odds
Table 5: Results of multiple logistic regression for high-cost case as outcome (n = 161, pseudo-R2 = 0.373).
Variable Odds Ratio 95% CI p
Age 18–24a 0.51 0.14–1.66 0.28
Age 65 and abovea 6.48 1.81–26.02 0.006
Hard method 3.38 1.22–9.82 0.02
ICD-10 F 1b 0.18 0.03–0.80 0.04
ICD-10 F 2b 0.76 0.19–2.86 0.68
ICD-10 F 4b 0.16 0.03–0.60 0.01
ICD-10 F 5/6b 0.30 0.05–1.41 0.15
Lethal intention 3.02 1.17–8.35 0.03
Female gender 1.88 0.69–5.42 0.23
History of migration 0.51 0.17–1.40 0.20
Intensive care 3.59 1.10–12.29 0.04
a Reference category age 25–64.
b Reference category ICD-10 F3.
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of being in the high-cost group. The association of “hard
methods” with male gender and higher costs might have
confounded the findings in univariate analysis. Ultimately,
“hard methods” seem to have a greater influence on costs
than gender (OR 3.38).
Our analysis indicated that subjects born in Switzerland
produced higher costs than individuals with a history of mi-
gration. Although the latter seem to produce lower costs
overall, there was no significant association with costs in
multivariate analysis. Possibly, this group is discharged
earlier from psychiatric treatment than natives, probably
due to limited language proficiency, which has recently
been shown in a study in our neighbour region [42]. Al-
though a speculative supposition, the deep cultural coher-
ence in some subgroups of individuals with a history of mi-
gration (e.g., of Turkish or Albanian origin) [43] may also
promote shorter hospital stays and an earlier discharge to
informal family care. Additionally, this group is less fre-
quently in the group of the elderly, which were shown to
generate higher costs.
Attempted and completed suicides may not only have a
severe impact on the patients’ family and friends, but also
on the professionals working with these patients [44], po-
tentially lowering their own health and productivity levels.
Future studies should aim to investigate indirect costs to
patients, caregivers and professionals to clarify the signi-
ficance for attempted suicide.
Limitations
Our study did not consider the costs of outpatient treatment
for other services and private practices, or direct non-med-
ical costs (e.g., counseling costs), because there is little de-
tailed data regarding number of suicide attempts treated in
this environment and the number of not registered cases is
considered high in Switzerland [12]. Furthermore, the in-
direct costs borne by patients and caregivers (e.g., attribut-
able to productivity losses or informal care) were not con-
sidered. Nevertheless, the study assesses cost components
already identified as crucial since current research identi-
fies indirect costs, ascribed to lost life years, as being the
major cost component for completed suicides, but direct
medical costs as being the major cost component for at-
tempted suicides. The generalisability of our results may
vary due to differences in health care systems. Further-
more, admission policies may differ by countries or even
regions. However, our sample has similar characteristics of
suicide attempters in other regions of Switzerland, and our
results may therefore be useful for clinicians and policy
makers in other settings. Furthermore, attempted suicide is
often associated with mental disorders and therefore one
might argue that direct costs cannot be allocated to attemp-
ted suicide without regard to the underlying psychiatric dis-
order. Some of the costs might be caused by the psychiatric
disorder and not necessarily be due to the suicide attempt.
However, suicide attempts are often the reason for the ini-
tiation of psychiatric treatment. Moreover, they may also
trigger crises of their own with a rise in cost due to intens-
ified treatment and potential supplemental somatic care.
To clarify that matter, more research comparing cost of sui-
cide events and general cost due to psychiatric illness is
needed.
Conclusions
Clearly, economic aspects should not be the only driver
in designing a policy for suicide prevention. But from a
health-economic perspective, the financial burden of sui-
cide attempts as such justifies appropriate and targeted in-
terventions. So far, few government-sponsored interven-
tion schemes have addressed this issue. Our results suggest
that specific subgroups, e.g. elderly patients or patients
with mood disorders, cause disproportionately high costs.
Programmes specifically targeting these groups could de-
liver a more attractive result in terms of economic out-
comes.
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Figures (large format)
Figure 1
Concentration curve of direct medical costs of suicide attempts (n = 176).
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